San Francisco, 20 December 2018: The Report Gastroesophageal Reflux Disease (GERD) Therapeutics Market Analysis By Drug Type (Antacids, Proton Pump Inhibitors,
H2 Receptor Blocker, Pro-Kinetic Agents), By Region, And Segment Forecasts,
2018 – 2025
The global Gastroesophageal Reflux Disease (GERD) therapeutics
market is expected to reach USD 4.34 billion
by 2025, according to a new study by Grand View Research, Inc. The incidence of
acid reflux disorder, also known as heartburn, is rapidly increasing worldwide.
Various studies state that almost every person experiences acid reflux once in
a lifetime.
 |
| GERD Therapeutics Market |
The overall market has been experiencing a
downturn in terms of revenue in the past several years as the leading drugs for
GERD treatment have lost their patent protection, with their market shares now
largely consumed by over-the-counter (OTC) and generic medications. Although
loss of exclusivity of high-grossing drugs have caused a market fall-off, the
demand for acid reducing drugs due to the high prevalence and incidence levels
of GERD will prove beneficial to the industry from a commercial standpoint.
GERD is one of the commonly observed
recurrent gastrointestinal disorders worldwide. The prevalence of acid reflux
and related symptoms has increased across the globe by nearly 50% over the last
decade. This disorder not only has major effects on the health and quality of
patient lives, but also extends to the healthcare system and economy.
In addition, the occurrence of acid reflux
disease increases with age, rendering elderly people more prone to developing a
severe form of heartburn. The geriatric subset hence forms a prominent target
population for GERD therapeutics.
Access Research Report of Gastroesophageal Reflux Disease
Therapeutics Market @ www.grandviewresearch.com/industry-analysis/gastroesophageal-reflux-disease-gerd-therapeutics-market
Further key findings from the study suggest:
· Antacids have been identified as the
largest drug type segment in terms of revenue share due to their cost-effectiveness
and greater consumer accessibility
· The rising trend of self-medication in case
of heartburn is particularly responsible for the growth in sales of OTC
antacids
· Proton pump inhibitors accounted for the
second largest segment as they are the most commonly prescribed medication for
the treatment of acid reflux
· Market share of proton pump inhibitors is
expected to decline over the forecast period with the loss of patent protection
of several leading drugs, such as Nexium and Prilosec, in this segment
· North America accounted for the largest
regional market in 2016 owing to the presence of a large patient population
suffering from heartburn and the availability of OTC generics
· On the other hand, Asia Pacific is expected
to grow at a fairly high growth rate as compared to other regional markets due to
increased adoption of OTC and generic antacids along with rising prevalence of
heartburn
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the GERD
therapeutics market on the basis of drug type and region:
GERD Therapeutics Drug Type Outlook
(Revenue, USD Million, 2014 - 2025)
·
Antacids
·
H2 Receptor Blockers
·
Proton Pump Inhibitors (PPIs)
·
Pro-kinetic agents
GERD Therapeutics Regional Outlook
(Revenue, USD Million, 2014 - 2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East and Africa (MEA)
Access Press Release of
Gastroesophageal Reflux Disease Therapeutics Market@
www.grandviewresearch.com/press-release/global-gastroesophageal-reflux-disease-gerd-therapeutics-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment